Erasca Inc. Common Stock vs Trane Technologies plc — how do they compare? Erasca Inc. Common Stock trades at $14.6 (market cap $5.17B), while Trane Technologies plc trades at $471.29 (market cap $105.17B). The key difference: Trane Technologies plc is far larger — about 20.3× Erasca Inc. Common Stock's market cap, and Trane Technologies plc pays a 0.88% dividend while Erasca Inc. Common Stock pays none. Which is the better fit depends on your goals.
| ERAS | TT | |
|---|---|---|
Market Cap | $5.17B | $105.17B |
Volume | 5,313,379 | 1,040,183 |
Sector | Health | Industrials |
52-Week High | $22.47 | $503.46 |
52-Week Low | $2.20 | $376.43 |
Typical Hold Time | 1 Days | — |
Enterprise Value | $4.95B | $108.47B |
Dividend Yield | — | 0.88% |
Signals from Pluang's Aura AI — not financial advice
ERAS trades at $14.78, down 4.4% today, with a bullish technical signal from moving averages and a consensus analyst price target of $22.50. The company is a clinical-stage oncology firm with no revenue, reporting a net loss of $124.55 million in 2025, but holds significant liquidity and has three potential registration-enabling trials ahead. Recent news highlights FDA Fast Track designation for its lead candidate ERAS-0015.
The outlook is speculative, driven by clinical trial progress; upside exists if trials succeed, but high cash burn and shareholder investigations pose substantial risks. Investment hinges on binary outcomes from drug development, making it suitable only for risk-tolerant investors focused on biotech.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.
Read more on ERAS →Trane Technologies plc is a global climate solutions company that designs, manufactures, and services heating, ventilation, and air conditioning (HVAC) and transport refrigeration equipment under its Trane and Thermo King brands.
Read more on TT →